Repair mechanisms help glioblastoma resist treatment
- PMID: 25444993
- DOI: 10.1016/j.jocn.2014.09.003
Repair mechanisms help glioblastoma resist treatment
Abstract
Glioblastoma multiforme (GBM) is a malignant and incurable glial brain tumour. The current best treatment for GBM includes maximal safe surgical resection followed by concomitant radiotherapy and adjuvant temozolomide. Despite this, median survival is still only 14-16 months. Mechanisms that lead to chemo- and radio-resistance underpin treatment failure. Insights into the DNA repair mechanisms that permit resistance to chemoradiotherapy in GBM may help improve patient responses to currently available therapies.
Keywords: Base excision repair; Glioma resistance; MGMT; PARP; Temozolomide chemotherapy.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.Expert Rev Anticancer Ther. 2012 May;12(5):635-42. doi: 10.1586/era.12.37. Expert Rev Anticancer Ther. 2012. PMID: 22594898 Review.
-
Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide.J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):441-6. doi: 10.1136/jnnp.2010.214593. Epub 2010 Sep 22. J Neurol Neurosurg Psychiatry. 2011. PMID: 20861061
-
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.J Clin Oncol. 2008 May 1;26(13):2192-7. doi: 10.1200/JCO.2007.14.8163. J Clin Oncol. 2008. PMID: 18445844
-
ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.J Transl Med. 2015 Feb 26;13:74. doi: 10.1186/s12967-015-0427-y. J Transl Med. 2015. PMID: 25886061 Free PMC article.
-
Association between response to primary treatments and MGMT status in glioblastoma.Expert Rev Anticancer Ther. 2008 Nov;8(11):1781-6. doi: 10.1586/14737140.8.11.1781. Expert Rev Anticancer Ther. 2008. PMID: 18983238 Review.
Cited by
-
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).Int J Oncol. 2015 Aug;47(2):417-28. doi: 10.3892/ijo.2015.3026. Epub 2015 May 29. Int J Oncol. 2015. PMID: 26035292 Free PMC article. Review.
-
RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma.Neuro Oncol. 2022 Aug 1;24(8):1261-1272. doi: 10.1093/neuonc/noac051. Neuro Oncol. 2022. PMID: 35231103 Free PMC article.
-
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review.Cancer Drug Resist. 2021;4(1):17-43. doi: 10.20517/cdr.2020.79. Epub 2021 Mar 19. Cancer Drug Resist. 2021. PMID: 34337348 Free PMC article.
-
MicroRNA-590-3p enhances the radioresistance in glioblastoma cells by targeting LRIG1.Exp Ther Med. 2017 Aug;14(2):1818-1824. doi: 10.3892/etm.2017.4697. Epub 2017 Jun 28. Exp Ther Med. 2017. PMID: 28810655 Free PMC article.
-
Amantadine against glioma via ROS-mediated apoptosis and autophagy arrest.Cell Death Dis. 2024 Nov 15;15(11):834. doi: 10.1038/s41419-024-07228-x. Cell Death Dis. 2024. PMID: 39548081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials